ProductUpdated on 29 August 2025
Innovative Human Platelet Lysate for Advanced Cell Culture
About
PL BioScience GmbH offers advanced human Platelet Lysate (HPL) products in both GMP grade and Research grade formulations, supporting robust cell growth in vitro and facilitating translation from laboratory research to regulated manufacturing processes. ELAREM™ Perform GMP Grade is produced under strict GMP and ISO 9001:2015 standards in Europe, using a closed sterile system and EU-sourced platelets, ensuring consistent quality in every batch. HPL serves as an animal-free, xeno-free alternative to Fetal Bovine Serum (FBS), providing growth factors and cytokines that support cell proliferation in various research and biopharmaceutical manufacturing settings. Gamma-irradiation is applied to enhance viral safety, aligning with safety management practices.
In September 2025, PL BioScience expanded its headquarters with a new 1,200 m² facility in Aachen, increasing production capacity up to 20,000 liters of HPL annually. This expansion supports the company’s ability to meet growing demand and accelerate product development.
PL BioScience is also developing an artificial HPL derived from lab-grown platelets using proprietary technology in collaboration with DewCell Biotherapeutics. Produced in Germany with raw materials from DewCell, this technology aims to provide an animal-free alternative to conventional HPL and FBS for research and manufacturing use. Recently, PL BioScience filed a patent for the process. This development represents a technological advancement in cell culture supplements.
Looking for
- Distribution Partner
Applies to
- Biotech and Lifescience
Attached files
Organisation
Similar opportunities
Project cooperation
- Execution
- Financing